Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab

Bibliographic Details
Main Authors: Chan, Arlene, McGregor, S.
Format: Journal Article
Published: Blackwell Publishing 2012
Online Access:http://hdl.handle.net/20.500.11937/49060
_version_ 1848758156660834304
author Chan, Arlene
McGregor, S.
author_facet Chan, Arlene
McGregor, S.
author_sort Chan, Arlene
building Curtin Institutional Repository
collection Online Access
first_indexed 2025-11-14T09:39:31Z
format Journal Article
id curtin-20.500.11937-49060
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:39:31Z
publishDate 2012
publisher Blackwell Publishing
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-490602017-03-15T22:55:36Z Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab Chan, Arlene McGregor, S. 2012 Journal Article http://hdl.handle.net/20.500.11937/49060 Blackwell Publishing restricted
spellingShingle Chan, Arlene
McGregor, S.
Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
title Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
title_full Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
title_fullStr Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
title_full_unstemmed Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
title_short Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
title_sort prevalence and management of her2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
url http://hdl.handle.net/20.500.11937/49060